We observed that sunitinib-resistant LL/2 cancer cells exhibited increased migration and invasion in vitro, and enhanced metastatic potential in vivo, companied by MMP2 and MMP9 overexpression, which play crucial roles in tumor invasion and metastasis [19, 20]. Here, MMP9 is linked to neoplasm.